Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2
- Shu Liu†1,
- David Hsieh†1,
- Yi-Lin Yang1,
- Zhidong Xu1,
- Csaba Peto1,
- David M Jablons1 and
- Liang You1Email author
© Liu et al.; licensee BioMed Central Ltd. 2013
Received: 18 March 2013
Accepted: 5 July 2013
Published: 11 July 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|18 Mar 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|17 Apr 2013||Reviewed||Reviewer Report - Cheryl Watson|
|2 May 2013||Reviewed||Reviewer Report - Laura Moro|
|4 Jun 2013||Author responded||Author comments - Shu Liu|
|Resubmission - Version 3|
|4 Jun 2013||Submitted||Manuscript version 3|
|7 Jun 2013||Reviewed||Reviewer Report - Cheryl Watson|
|17 Jun 2013||Reviewed||Reviewer Report - Laura Moro|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|5 Jul 2013||Editorially accepted|
|11 Jul 2013||Article published||10.1186/2050-6511-14-36|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.